Articles

Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II receptor blockers (ARBs) can allow coronavirus entry, leading to pulmonary adverse effects.

The mechanisms by which estrogens improve glucose homeostasis are not completely understood.

Old drug, new purpose? Analysis found HIV and Hepatitis B patients treated with NRTIs had significantly lower incidence of type 2 diabetes.

How often are opioids being initiated for diabetic peripheral neuropathy (DPN) in newly diagnosed patients?

New vaccines targeting viruses linked with type 1 diabetes may offer protection to patients with high-risk factors.

The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events. 

Behavioral changes during the pandemic can improve blood glucose control.

Tirzepatide is both a GIP and GLP-1 receptor agonist. 

Results of an extensive retrospective study indicate a strong association between glomerular filtration (eGFR) rate and cardiovascular disease morbidity rate.

Better understanding of how certain viral infections may increase the incidence of type 1 diabetes could lead to new strategies for prevention.